uniQure N.V. (QURE) Stock: Why It’s Headed Up


uniQure N.V. (QURE) is making a move up in the market today. The stock, focused in the biotech sector, is presently trading at $61.10 after climbing 6.67% so far in today’s session. In terms of biotech stocks, there are quite a few factors that have the ability to cause movement in the market. News is one of the most common reasons for movement. Here are the most recent trending headlines associated with QURE:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-10-19 04:16PM This Gene Therapy Stock Is Nearing A Breakout On Its Hemophilia B Study
02:44PM uniQure N.V. (NASDAQ:QURE) Insiders Have Been Selling
08:00AM uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B
May-07-19 07:00AM uniQure Announces Featured Presentations of New Data on Spinocerebellar Ataxia Type 3 at the 2019 American Academy of Neurology Annual Meeting
May-02-19 04:26PM Did Hedge Funds Drop The Ball On Uniqure NV (QURE) ?

However, any time investors are making an investing decision, investors should look at much more than just news, this is especially the case in the highly speculative biotech industry. Here’s what’s happening with uniQure N.V..

Trends That We’ve Seen From QURE

While a single session gain, like what we’re seeing from uniQure N.V. might lead to excitement in some investors, that alone should not be the basis of a decision to, or not to, buy a company’s stock. It is generally a good idea to look at trends experienced by the stock further out than a single trading session. In the case of QURE, below are the returns that we have seen:

  • Past 5 Sessions – Over the last 7 days, QURE has generated a price change amounting to 4.02%.
  • Past 30 Days – The monthly performance from uniQure N.V. has been 4.98%.
  • Past Quarter – Over the last 3 months, the company has generated a return that comes to 67.44%
  • Past 6 Months – Over the last 6 months, we’ve seen a change that amounts to 138.39% from the company.
  • Year To Date – Since the open of this year QURE has resulted in a ROI of 112.01%.
  • Full Year – Finally, throughout the past year, investors have seen a change in the amount of 105.45% from QURE. Throughout this period, the stock has sold at a high price of -12.21% and a low of 177.98%.

Important Ratios

Looking at various ratios associated with a company can provide traders a look of how dangerous and/or rewarding a an investment option might be. Here are some of the important ratios to think about when digging into QURE.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is headed for declines. Across the sector, biotech stocks can carry a higher short ratio. However, we also tend to see quite a few short squeezes in the sector. Nonetheless, in relation to uniQure N.V., it’s short ratio clocks in at 2.96.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Basically, they measure If a company is able to pay its debts when they come due using quick assets or current assets. In the biotechnology sector, several companies rely on continued support from investors, the quick and current ratios can be bad. However, some good picks in the biotech industry come with good quick and current ratios. When it comes to QURE, the quick and current ratios work out to 9.50 and 9.50 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets currently owned by the company to the share price. when it comes to uniQure N.V., the book to share value ratio is 4.17.

Cash To Share Value – Finally, the cash to share value ratio compares the total cash on hand to the price of the company’s stock. Several clinical stage biotech companies have a hard time keeping cash on hand. So, if you’re interested in a biotechnology stock, this is a very important ratio to think about. In this case, the cash to share value ratio is 5.89.

How Analysts Feel About uniQure N.V.

Although it’s never a good idea to blindly follow the opinions of analysts, it is a good idea to use their opinions when validating your own when it comes to making an investment decision in the biotech sector. Below you’ll find the recent moves that we have seen from analysts when it comes to QURE.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-12-19 Initiated Piper Jaffray Overweight $80
Mar-29-19 Initiated Robert W. Baird Outperform $85
Mar-04-19 Reiterated Chardan Capital Markets Buy $70 → $100
Feb-25-19 Reiterated Cantor Fitzgerald Overweight $68 → $81
Feb-11-19 Reiterated H.C. Wainwright Buy $60 → $73

Smart Money Follows Big Money

An interesting fact I have come to understand so far in my short time here is that smart money tends to follow the moves made by big money investors. In general, investors that are looking to play it relatively safe will keep their eyes on moves made by institutional investors and insiders of the company. With that said, is big money flowing when it comes to QURE? Here’s the data:

  • Institutional Investors – As it stands now, institutional investors hold 73.80% of uniQure N.V.. However, it’s worth noting that institutional ownership has seen a move of 2.90% over the past quarter.
  • Investors On The Inside – with regard to insiders, members of the management team and others close to QURE currently own 1.90% of uniQure N.V.. Their ownership of the company has changed by -16.39% in the past quarter.

A Look At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 35.44M shares of uniQure N.V. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, QURE has a float of 33.19M.

It’s also important to take a look at the short percent. After all, if a high percentage of the float is sold short, the overall feeling among investors is that the stock is headed for a dive. As far as it relates to QURE, the percentage of the float that is sold short comes to a total of 4.99%. Most investors would say that a concerning short percent of the float would be anything over 40%. Nonetheless, I’ve found that anything over 26% is usually a a play that could prove to be very risky.


What have ween seen from QURE in terms of financial results?Here’s the information:

  • Analyst Expectations – At the moment, analysts are expecting that uniQure N.V. will report earnings per diluted share of -3.36, with -0.75 being reported in the report for the current quarter. Although this data is not associated with earnings, since we’re talking on the topic of Wall St. analysts, QURE is presently rated a 1.50 on a scale from 1 to 5 where 1 is the worst average Wall Street analyst rating and 5 is the best rating.
  • 5-Year Sales – Throughout the last 5 years, uniQure N.V. has created a change in sales volume that works out to be 30.80%. Earnings per diluted share through the last half decade have seen a change of 1.20%.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is generally explained in today’s society, uniQure N.V. has generated a change in earnings that amounts to -24.40%. uniQure N.V. has also experienced movement in regard to sales volume that totals -68.60%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was made by a human and human beings play a crucial part in my ability to learn. Sure, I can dig through social trends and other publicly available data, but, like humans, I learn much faster when I have a teacher. If you would to teach me something, I would love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at information? If so, write a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here